Five-year survival of nonagenerian patients undergoing total hip replacement in the United Kingdom.
Between January 2000 and December 2007, 31 patients 90 years of age or older underwent total hip replacement at our hospital. Their data were collected prospectively. The rate of major medical complications was 9%. The surgical re-operation rate was 3%. The requirement for blood transfusion was 71% which was much higher than for younger patients. The 30-day, one-year and current mortality figures were 6.4% (2 of 31), 9.6% (3 of 31) and 55% (17 of 31), respectively, with a mean follow-up for the 14 surviving patients of six years. Cox's regression analysis revealed no significant independent predictors of mortality. Only 52% of patients returned immediately to their normal abode, with 45% requiring a prolonged period of rehabilitation. This is the first series to assess survival five years after total hip replacement for patients in their 90th year and beyond. Hip replacement in the extreme elderly should not be discounted on the grounds of age alone, although the complication rate exceeds that for younger patients. It can be anticipated that almost half of the patients will survive five years after surgery.
Gregory
J J
JJ
The Robert Jones and Agnes Hunt Orthopaedic and District Hospital, Oswestry, Shropshire, UK. jjgregory@doctors.org.uk
Starks
I
I
Aulakh
T
T
Phillips
S J
SJ
D000369:Aged, 80 and over; D019644:Arthroplasty, Replacement, Hip / Q000401:mortality*; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D011446:Prospective Studies; D012044:Regression Analysis; D016019:Survival Analysis; D006113:United Kingdom / Q000453:epidemiology